Results for: IBD

man with upset stomach caused by ibd

June 15, 2017

Researchers Uncover New Immunometabolic Target for Inflammatory Bowel Disease Treatments

Researchers at the Biocomplexity Institute of Virginia Tech have discovered a new therapeutic target for inflammatory bowel disease, and it’s right inside our immune cells: a gene known as NLRX1.

March 20, 2017

Solving the Immunity Puzzle Takes Collaboration Among Different Fields

Studying the human immune system is like trying to work a vast, multidimensional jigsaw puzzle with pieces that are constantly changing shape. A recent paper in Trends in Immunology explores how technology is helping scientists arrive at faster, more effective solutions.

July 07, 2016

Advancing Precision Medicine: Computational Immunology for Next-Generation Healthcare

The Biocomplexity Institute is developing new research technologies that offer a promising alternative to the "one-size-fits-all" approach to wellness. Our approach to precision combines traditional wet lab studies with advanced computational modeling.

March 16, 2012

Researchers discover novel therapy for Crohn’s disease

BLACKSBURG, Va., March 16, 2012 – The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) research team at Virginia Tech has discovered important new information on the efficacy of conjugated linoleic acid (CLA) in treating Crohn’s disease, a form of inflammatory bowel disease (IBD).  CLA is a naturally occurring fatty acid found in meat and dairy products known for its anti-cancer and immune modulatory properties.

October 05, 2011

Center for Modeling Immunity to Enteric Pathogens Releases Revolutionary Software

BLACKSBURG, Va., Oct. 5th, 2011 - Researchers from the Center for Modeling Immunity to Enteric Pathogens (MIEP) at the Virginia Bioinformatics Institute have released an upgrade to the revolutionary ENteric Immunity SImulator (ENISI) software. ENISI models immune responses to beneficial and harmful bacteria that enter the gastrointestinal tract (GI) of mice, pigs and humans. ENISI allows users to create enteric systems such as the gut-associated mucosal immune system in silico, providing a better glimpse of how the immune system responds to pathogens that invade the bacteria-rich environment of the gut.